Today's the reason why Buy and Hold works best

Cochlear Limited (ASX:COH) and M2 Group Ltd (ASX:MTU) in the top 3 gainers of the ASX 200 today

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In mid-afternoon trading, the S&P/ASX 200 index (Index: ^AXJO) (ASX: XJO) had slumped 0.4%, despite gains on US markets overnight.

But what the market is doing doesn't mean much for my portfolio. It's up more than 1% so far today, thanks to my strategy of buy and hold. 'Buy and Hold' gets a lot of flack, mostly from people who don't understand it.

It's a very simple strategy, but requires plenty of patience, and lots of inactivity.

Showing how much of an effect high frequency trading (HFT) is having and fund managers prone to becoming more 'active', holding periods of US stocks have dropped from seven years in 1955 to just over three months in 2012. The latest statistics for the ASX suggest a holding period of less than 12 months.

That's not buy and hold folks.

Here are two of my examples of buy and hold.

I bought shares in Cochlear Limited (ASX: COH) more than six years ago and have never sold a single one, despite all the issues the hearing implant maker has gone through in recent times with the recall of its top line processor and subsequent struggles to regain market position and grow revenues once again.

I've topped up along the way, even managing to buy some at around $53 last year. Over the six years, I've received thousands of dollars of dividends, and I intend to keep holding as the company's fortunes turn around. Cochlear shares are up 10% in mid-afternoon trading at $68.78.

Another example is telecommunications company M2 Group Ltd (ASX: MTU). I bought shares in M2 three years ago, and have never sold any, despite a number of large short-term falls along the way. And again, I've topped up as shares were sold off. Today, M2's shares are up 2.5% at $6.11. Will I be selling soon? Nope.

Now that's a simple, easy to understand and implement (almost lazy) strategy. No massive brokerage fees for me, and I didn't have to spend all day watching the markets or trading.

Is it time you gave it a go?

Motley Fool writer/analyst Mike King owns shares in Cochlear and M2 Communications. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »